ASYMMETRIC DIMETHYLARGININE LEVELS AND ATHEROSCLEROSIS MARKERS IN CUSHING SYNDROME

Ozsurekci C. G., Akturk M. Y., Ozkan C., Gülbahar Ö., Altinova A., Yalcin M. M., ...Daha Fazla

ENDOCRINE PRACTICE, cilt.22, sa.9, ss.1088-1095, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 9
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4158/ep15990.or
  • Dergi Adı: ENDOCRINE PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1088-1095
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: As a consequence of hypercortisolism, Cushing syndrome (CS) is frequently observed with other diseases that are associated with atherosclerosis, including diabetes mellitus, dyslipidemia, hypertension, and obesity. Cardiovascular disease (CVD) is the primary cause of mortality and morbidity in CS. We investigate CVD risk markers such as asymmetric dimethylarginine (ADMA), lipoprotein-associated phospholipase A2 (Lp-PLA2), high-sensitive C-reactive protein (hsCRP), homocysteine, lipid levels, ankle-brachial index (ABI), and carotid intima-media thickness (CIMT) in CS.